Clinical Trials Directory

Trials / Completed

CompletedNCT05080283

Acceptance and Performance of CP1110 Sound Processor With Experienced Adult Cochlear Implant Recipients.

A Pre-Marketing, Prospective, Single-Site, Open-Label, Within-Subject, Actual-Use, Interventional Study of Acceptance and Performance With Experienced Adult Cochlear Implant Recipients Using the CP1110 Sound Processor Compared With the CP1000 Sound Processor

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Cochlear · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The clinical study aims to investigate acceptance, actual-use usability and speech performance with a new behind-the-ear sound processor (model number: CP1110) system, compared with the commercially available Nucleus 7 Sound Processor (model: CP1000) system, with particular focus on the acceptance of and satisfaction with a noise reduction feature in the Automatic Scene Classifier 'SCAN 2'.

Detailed description

The clinical study aims to investigate acceptance, actual-use usability and speech performance with a new behind-the-ear sound processor (model number: CP1110) system, compared with the commercially available Nucleus 7 Sound Processor (model: CP1000) system, with particular focus on the acceptance of and satisfaction with a noise reduction feature in the Automatic Scene Classifier 'SCAN 2'. This study will build on the evidence collected in previous Nucleus 7 Sound Processor take home studies and will also aim to confirm the in-booth performance of CP1110 and Nucleus 7 Sound Processors.

Conditions

Interventions

TypeNameDescription
DEVICECP1110 Sound Processor System with automated ForwardFocus On (SCAN 2 FF)Sound Processor
DEVICENucleus 7 Sound Processor (model: CP1000) systemSound Processor
DEVICECP1110 Sound Processor System with ForwardFocus Off (SCAN 2)Sound Processor

Timeline

Start date
2021-11-02
Primary completion
2022-09-13
Completion
2022-09-13
First posted
2021-10-15
Last updated
2025-03-25
Results posted
2025-03-25

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT05080283. Inclusion in this directory is not an endorsement.